Procter & Gamble, US7427181091

Procter & Gamble stock draws attention after CEO sells 2,225 shares

Published on 10/07/2026 at 16:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Procter & Gamble stock traded at USD 149.10 on October 7, 2026, while CEO Paul Gama sold 2,225 shares. Fiscal 2026 sales rose 3 percent to USD 87.0 billion.

Heller Supermarktgang mit Regalen voll ungebrandeter Haushalts- und Pflegeprodukte in Pastelltönen
Procter und Gamble US7427181091 zeigt breite Supermarkt Regale mit generischen Pflegeprodukten in hellen Pastellfarben, Illustration mit AI erstellt.

Procter & Gamble stock (ISIN US7427181091) was trading at USD 149.10 on the NYSE on October 7, 2026, at 10:58 a.m. ET. The immediate company-specific signal came from an insider filing: StockTitan reported on October 6, 2026, that CEO Paul Gama sold 2,225 shares at USD 145.34 on October 5, 2026.

CEO sale tied to stock awards

The transaction was valued at USD 323,381.50, and the filing said the shares were sold to cover a tax obligation linked to the settlement of a restricted stock unit award. Gama held 51,124 directly owned shares after the sale, according to the filing reported by StockTitan.

The stated tax purpose gives the transaction a different signal from an open-market disposal based on a change in management's view. For investors, the more important test remains whether sales growth and margins can support the valuation before the next results release.

Sales rose in fiscal 2026

Procter & Gamble's fiscal 2026 net sales reached USD 87.0 billion, up 3 percent from the prior fiscal year, while core EPS increased 1 percent. Operating cash flow was USD 19.6 billion for fiscal 2026, according to Procter & Gamble Investor Relations.

The comparison shows the current balance: revenue growth accelerated from USD 84.3 billion in fiscal 2025 to USD 87.0 billion in fiscal 2026, while diluted EPS rose from USD 6.51 to USD 6.62. Operating cash flow also increased from USD 17.8 billion to USD 19.6 billion over the same periods.

Consensus points above the price

StockHub lists a Moderate Buy consensus from 23 analysts, with a median target of USD 162.00 and a target range of USD 143.00 to USD 186.00. The median target is 8.65 percent above the USD 149.10 NYSE price on October 7, 2026.

That spread leaves the upcoming earnings discussion as the next measurable checkpoint. Procter & Gamble Investor Relations said the company will discuss first-quarter fiscal 2027 results on October 22, 2026, at 8:30 a.m. ET.

NYSE value and next dates

Procter & Gamble carried a market capitalization of USD 354.4 billion on October 7, 2026. The share traded 0.46 percent above the prior close of USD 148.41, with a 52-week range of USD 137.62 to USD 167.25.

Procter & Gamble stock facts

  • Company: The Procter & Gamble Company
  • ISIN: US7427181091
  • Ticker: PG
  • Trading venue: NYSE
  • Price (as of October 7, 2026, 10:58 a.m. ET): USD 149.10
  • Market capitalization: USD 354.4 billion (as of October 7, 2026)
  • 52-week range: USD 137.62-167.25
  • Sector / Industry: Consumer Staples

Upcoming dates for Procter & Gamble stock

  • October 13, 2026: Virtual annual meeting of shareholders
  • October 22, 2026: First-quarter fiscal 2027 earnings discussion

More news and analyses on Procter and Gamble stock

Disclaimer...

en | US7427181091 | PROCTER & GAMBLE | boerse | 70257090 | bgmi